Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$1.04 - $1.4 $9,974 - $13,427
9,591 New
9,591 $10,000
Q2 2022

Aug 12, 2022

SELL
$0.67 - $1.4 $4,013 - $8,387
-5,991 Closed
0 $0
Q2 2020

Aug 05, 2020

BUY
$1.83 - $4.06 $10,963 - $24,323
5,991 New
5,991 $17,000
Q2 2019

Aug 14, 2019

SELL
$1.79 - $3.05 $1,841 - $3,138
-1,029 Closed
0 $0
Q2 2017

Aug 15, 2017

BUY
N/A
1,029
1,029 $20,000

Others Institutions Holding SELB

About SELECTA BIOSCIENCES INC


  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.